Delivery Order SPE2DR25D1002-SPE2DR26FGJ2F
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of VIVITROL 380 mg vial-diluents. This competitive award, utilizing firm fixed-price pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The delivery order carries an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,004.68 to AmerisourceBergen Drug Corp for the supply of VIVITROL 380 MG vial-diluents, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,001.17 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with a completion date of September 24, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,017.66 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This...
- The Defense Logistics Agency awarded a $45,056.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Vivitrol 380 mg vial-diluents. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and was awarded competitively without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,636.97 firm fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of VIVITROL 380 MG VIAL-DILUENTS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- The Defense Logistics Agency (DLA) awarded a $2,002.34 delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. VIVITROL is an extended-release injectable medication used primarily for opioid use disorder treatment, making...
- The Defense Logistics Agency (DLA) awarded a $6,007.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vivitrol 380 mg vials and diluents. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. Vivitrol is a medication used for opioid use disorder treatment, and this delivery order represents a specific pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,730.90 on October 27, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGJ2FDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,055.07 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract, which became effective on October 30, 2025, with an ultimate completion date of October 31, 2025, is a firm fixed-price arrangement with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. Vivitrol (naltrexone extended-release injection) is a medication used in opioid use disorder treatment, and the diluents are essential components required for reconstituting and administering this pharmaceutical product across federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contracts demonstrating its capability to fulfill complex medical supply requirements for the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/30/25 |